Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
FEZ2/Zygin2 Rabbit anti-Human, Polyclonal, Bioss

Rabbit Polyclonal Antibody
Supplier: Bioss BS11840R

Description
Fasciculation and elongation protein zeta-2 (FEZ2) is a homolog to the mammalian FEZ1, itself an ortholog of the C. elegans UNC-76. In contrast to FEZ1, FEZ2 mRNA is widely expressed in mouse tissues. FEZ2 interacts with protein kinase C (PKC)-zeta substrate and induces neurite extension of PC12 cells when co-expressed with a constitutively active form of PKC-zeta, suggesting FEZ2 may play an important role in the morphological changes of various cells by associating with PKC-zeta in a tissue non-specific manner. FEZ2 can interact with FEZ1 through its c-terminal regions and especially its coiled-coil region. At least two isoforms of FEZ2 are known to exist.Specifications
FEZ2/Zygin2 | |
Polyclonal | |
Unconjugated | |
FEZ2 | |
9030616F16; D17Ertd315e; fasciculation and elongation protein zeta 2; fasciculation and elongation protein zeta 2 (zygin II); Fasciculation and elongation protein zeta-2; FEZ2; HUM3CL; pre-T/NK cell associated protein (3Cl); synaptotagmin interacting protein zyginII; Zrp; zygin 2; Zygin II; Zygin-2; Zygin-related protein types I/II | |
Rabbit | |
Protein A | |
RUO | |
9637 | |
-20°C | |
Liquid |
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot | |
1 μg/mL | |
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH | |
Q9UHY8 | |
FEZ2 | |
KLH conjugated synthetic peptide derived from human FEZ2/Zygin2. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction